• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘表型:从临床方法到分子方法的演变。

Asthma phenotypes: the evolution from clinical to molecular approaches.

机构信息

University of Pittsburgh Asthma Institute at UPMC and the University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

出版信息

Nat Med. 2012 May 4;18(5):716-25. doi: 10.1038/nm.2678.

DOI:10.1038/nm.2678
PMID:22561835
Abstract

Although asthma has been considered as a single disease for years, recent studies have increasingly focused on its heterogeneity. The characterization of this heterogeneity has promoted the concept that asthma consists of multiple phenotypes or consistent groupings of characteristics. Asthma phenotypes were initially focused on combinations of clinical characteristics, but they are now evolving to link biology to phenotype, often through a statistically based process. Ongoing studies of large-scale, molecularly and genetically focused and extensively clinically characterized cohorts of asthma should enhance our ability to molecularly understand these phenotypes and lead to more targeted and personalized approaches to asthma therapy.

摘要

尽管哮喘多年来一直被认为是一种单一的疾病,但最近的研究越来越关注其异质性。这种异质性的特征描述促进了这样一种概念,即哮喘由多种表型或一致的特征分组组成。哮喘表型最初侧重于临床特征的组合,但现在正在发展为将生物学与表型联系起来,通常通过基于统计学的过程。正在进行的大规模、分子和遗传为重点的研究,以及对哮喘进行广泛临床特征描述的队列研究,应该增强我们从分子上理解这些表型的能力,并导致更有针对性和个性化的哮喘治疗方法。

相似文献

1
Asthma phenotypes: the evolution from clinical to molecular approaches.哮喘表型:从临床方法到分子方法的演变。
Nat Med. 2012 May 4;18(5):716-25. doi: 10.1038/nm.2678.
2
Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes.理解哮喘的免疫学:哮喘表型的病理生理学、生物标志物和治疗方法。
Paediatr Respir Rev. 2020 Nov;36:118-127. doi: 10.1016/j.prrv.2019.08.002. Epub 2019 Oct 9.
3
Asthma Phenotypes as a Guide for Current and Future Biologic Therapies.哮喘表型作为当前和未来生物疗法的指导。
Clin Rev Allergy Immunol. 2020 Oct;59(2):160-174. doi: 10.1007/s12016-019-08760-x.
4
Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?分子表型分析与生物标志物开发:我们是否正在迈向重度哮喘的靶向治疗?
Expert Rev Respir Med. 2016;10(1):29-38. doi: 10.1586/17476348.2016.1111763. Epub 2015 Nov 13.
5
Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.哮喘表型和生物药物在哮喘和过敏性疾病中的应用:迈向个体化治疗的下一步。
J Allergy Clin Immunol. 2015 Feb;135(2):299-310; quiz 311. doi: 10.1016/j.jaci.2014.12.1871.
6
Phenotypes/endotypes-driven treatment in asthma.基于表型/内型的哮喘治疗
Curr Opin Allergy Clin Immunol. 2018 Jun;18(3):184-189. doi: 10.1097/ACI.0000000000000440.
7
Emerging molecular phenotypes of asthma.哮喘的新兴分子表型
Am J Physiol Lung Cell Mol Physiol. 2015 Jan 15;308(2):L130-40. doi: 10.1152/ajplung.00070.2014. Epub 2014 Oct 17.
8
Severe asthma: from characteristics to phenotypes to endotypes.严重哮喘:从特征到表型再到内型。
Clin Exp Allergy. 2012 May;42(5):650-8. doi: 10.1111/j.1365-2222.2011.03929.x. Epub 2012 Jan 18.
9
Severe asthma phenotypes and endotypes.严重哮喘表型和内型。
Semin Immunol. 2019 Dec;46:101301. doi: 10.1016/j.smim.2019.101301. Epub 2019 Aug 27.
10
Developing and emerging clinical asthma phenotypes.发展中与新兴的临床哮喘表型。
J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):671-80; quiz 681. doi: 10.1016/j.jaip.2014.09.007. Epub 2014 Oct 5.

引用本文的文献

1
Baseline characteristics of patients from the Brazilian Severe Asthma Registry: the REBRAG study.巴西重症哮喘登记处患者的基线特征:REBRAG研究。
J Bras Pneumol. 2025 Sep 8;51(3):e20240427. doi: 10.36416/1806-3756/e20240427. eCollection 2025.
2
Investigating the Underlying Mechanisms of Ma-Xing-Shi-Gan-Tang on Asthma via Metabolomics and Network Pharmacology.基于代谢组学和网络药理学探究麻杏石甘汤治疗哮喘的潜在机制
J Inflamm Res. 2025 Aug 18;18:11245-11262. doi: 10.2147/JIR.S515631. eCollection 2025.
3
Targeting ADAM17 to dampen dendritic cell-mediated type 2 immune responses and airway inflammation associated with allergic asthma.

本文引用的文献

1
Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation.哮喘中的一氧化氮和相关酶:与严重程度、酶功能和炎症的关系。
Clin Exp Allergy. 2012 May;42(5):760-8. doi: 10.1111/j.1365-2222.2011.03860.x. Epub 2011 Sep 25.
2
An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.美国胸科学会临床实践指南:呼出气一氧化氮(FENO)检测在临床中的应用解读。
Am J Respir Crit Care Med. 2011 Sep 1;184(5):602-15. doi: 10.1164/rccm.9120-11ST.
3
Lebrikizumab treatment in adults with asthma.
靶向ADAM17以抑制树突状细胞介导的2型免疫反应及与过敏性哮喘相关的气道炎症。
Sci Rep. 2025 Aug 25;15(1):31253. doi: 10.1038/s41598-025-14569-w.
4
A combination of silica and cigarette smoke extract exacerbates lung fibrosis: Unveiling a harmful synergy.二氧化硅与香烟烟雾提取物的组合会加剧肺纤维化:揭示一种有害的协同作用。
PLoS One. 2025 Aug 22;20(8):e0330762. doi: 10.1371/journal.pone.0330762. eCollection 2025.
5
Obesity indicators and female asthma risk: the mediating role of white blood cell count based on NHANES data analysis.肥胖指标与女性哮喘风险:基于美国国家健康与营养检查调查(NHANES)数据分析的白细胞计数的中介作用
BMC Pulm Med. 2025 Aug 21;25(1):399. doi: 10.1186/s12890-025-03885-6.
6
Sputum Transcriptomic Analysis and Clustering Reveals Insight Into Asthma Heterogeneity.痰液转录组分析与聚类揭示哮喘异质性
Lung. 2025 Aug 20;203(1):89. doi: 10.1007/s00408-025-00843-1.
7
Childhood Asthma Biomarkers Derived from Plasma and Saliva Exosomal miRNAs.源自血浆和唾液外泌体微小RNA的儿童哮喘生物标志物
Int J Mol Sci. 2025 Jul 22;26(15):7043. doi: 10.3390/ijms26157043.
8
Blood cell perturbation responses mediate the causal relationship between the gut microbiota and asthma: a bidirectional Mendelian randomization study.血细胞扰动反应介导肠道微生物群与哮喘之间的因果关系:一项双向孟德尔随机化研究。
BMC Med Genomics. 2025 Aug 6;18(1):127. doi: 10.1186/s12920-025-02196-3.
9
A mucosal vaccine prevents eosinophilic allergic airway inflammation by modulating immune responses to allergens in a murine model of airway disease.在气道疾病小鼠模型中,一种黏膜疫苗通过调节对过敏原的免疫反应来预防嗜酸性粒细胞性过敏性气道炎症。
Nat Commun. 2025 Aug 3;16(1):7129. doi: 10.1038/s41467-025-62632-x.
10
Non-Coding RNAs in Asthma: Regulators of Eosinophil Biology and Airway Inflammation.哮喘中的非编码RNA:嗜酸性粒细胞生物学和气道炎症的调节因子
Diagnostics (Basel). 2025 Jul 10;15(14):1750. doi: 10.3390/diagnostics15141750.
来氟米特治疗成人哮喘。
N Engl J Med. 2011 Sep 22;365(12):1088-98. doi: 10.1056/NEJMoa1106469. Epub 2011 Aug 3.
4
Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation.肥胖和减重手术对气道高反应性、哮喘控制和炎症的影响。
J Allergy Clin Immunol. 2011 Sep;128(3):508-15.e1-2. doi: 10.1016/j.jaci.2011.06.009. Epub 2011 Jul 23.
5
Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma.鉴定慢性哮喘小鼠模型中的 IFN-γ/肥大细胞轴。
J Clin Invest. 2011 Aug;121(8):3133-43. doi: 10.1172/JCI43598.
6
Obesity and asthma: an association modified by age of asthma onset.肥胖与哮喘:与哮喘发病年龄相关的关联。
J Allergy Clin Immunol. 2011 Jun;127(6):1486-93.e2. doi: 10.1016/j.jaci.2011.03.036.
7
IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma.IL-33 在哮喘小鼠模型中连接组织细胞、树突状细胞和 Th2 细胞的发育。
Eur J Immunol. 2011 Jun;41(6):1535-8. doi: 10.1002/eji.201141668.
8
Interaction between adaptive and innate immune pathways in the pathogenesis of atopic asthma: operation of a lung/bone marrow axis.变应性哮喘发病机制中适应性免疫与固有免疫通路的相互作用:肺/骨髓轴的作用。
Chest. 2011 May;139(5):1165-1171. doi: 10.1378/chest.10-2397.
9
Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.奥马珠单抗治疗标准治疗控制不佳的严重变应性哮喘:一项随机试验。
Ann Intern Med. 2011 May 3;154(9):573-82. doi: 10.7326/0003-4819-154-9-201105030-00002.
10
Childhood eczema and rhinitis predict atopic but not nonatopic adult asthma: a prospective cohort study over 4 decades.儿童特应性皮炎和鼻炎可预测特应性而非非特应性成人哮喘:一项超过 4 十年的前瞻性队列研究。
J Allergy Clin Immunol. 2011 Jun;127(6):1473-9.e1. doi: 10.1016/j.jaci.2011.02.041. Epub 2011 Apr 1.